These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30153192)

  • 21. Bridging the gap in treatment options for patients with hypertriglyceridemia.
    Underberg JA; Hays R
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering medications for children and adolescents.
    Miller ML; Wright CC; Browne B
    J Clin Lipidol; 2015; 9(5 Suppl):S67-76. PubMed ID: 26343214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimal lipid treatment: possibilities and current limitations].
    Klose G
    Internist (Berl); 2011 Mar; 52(3):328-35. PubMed ID: 21331642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice. Hypertriglyceridemia.
    Brunzell JD
    N Engl J Med; 2007 Sep; 357(10):1009-17. PubMed ID: 17804845
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
    Nichols GA; Reynolds K; Olufade T; Kimes TM; O'Keeffe-Rosetti M; Sapp DS; Anzalone D; Fortmann SP
    Am J Cardiol; 2017 Feb; 119(3):410-415. PubMed ID: 27890243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review.
    Plaisance EP; Grandjean PW; Mahurin AJ
    Phys Sportsmed; 2009 Apr; 37(1):11-9. PubMed ID: 20048483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing Hypertriglyceridemia in Daily Practice.
    Pramono LA; Harbuwono DS
    Acta Med Indones; 2015 Jul; 47(3):265-71. PubMed ID: 26586394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy.
    Kataoka Y; Uno K; Puri R; Nicholls SJ
    Future Cardiol; 2013 Mar; 9(2):177-86. PubMed ID: 23463969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological control of hypertriglyceridemia.
    Franceschini G; Paoletti R
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):297-302. PubMed ID: 8364001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertriglyceridemia: management of atherogenic dyslipidemia.
    Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
    J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation and management of hypertriglyceridaemia.
    Ferns G; Keti V; Griffin B
    J Clin Pathol; 2008 Nov; 61(11):1174-83. PubMed ID: 18955574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridemia: the importance of identifying patients at risk.
    Kushner PA; Cobble ME
    Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing challenges for pharmacotherapy for dyslipidemia.
    Pisaniello AD; Scherer DJ; Kataoka Y; Nicholls SJ
    Expert Opin Pharmacother; 2015 Feb; 16(3):347-56. PubMed ID: 25476544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of LDL subclass B in patients at cardiovascular risk.
    Moredich C; Kark D; Keresztes P
    Nurse Pract; 2005 Jul; 30(7):16-8, 23, 26, passim; quiz 29-31. PubMed ID: 16021026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.